Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
[PMID: 38311483] Laboratory literature summary: Could semaglutide be related to increasing the risk of developing a disordered eating
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
Old MRP 54.75 MRP 51.33 *MRP inclusive of all taxes Prescription required for this medicine Composition Benzyl Alcohol (2 %) + Methylcobalamin (2500 Mcg) BIGVIN 2500 INJECTION 1ML is used to manage vitamin B12 deficiency and peripheral neuropathy
Our platform calculates how much to reconstitute based on your dosing frequency, tracks when vials were reconstituted (automatic 28-day countdown), and suggests when to discard and reconstitute fresh batches
US$ 22.66
US$ 26.07
US$ 27.48
US$ 25.51
